Trial intelligence / Profile preview

TRV130 for Acute Postoperative Pain Following Abdominoplasty

NCT02335294Phase 2Completed

Sponsor
Trevena, Inc.
Start
Dec 2014
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of oliceridine in acute postoperative pain, sponsored by Trevena, Inc.. Started Dec 2014; status: completed.

02

Drugs

oliceridine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT02335294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02335294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call